Cargando…

Targeting proliferation and survival pathways in head and neck cancer for therapeutic benefit

Head and neck squamous cell carcinomas (HNSCC) are common human malignancies with poor clinical outcomes. The 5-year survival rates for patients with advanced stage HNSCC have not changed appreciably in the past few decades, underscoring a dire need for improved therapeutic options. Recent studies h...

Descripción completa

Detalles Bibliográficos
Autor principal:	Johnson, Daniel E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sun Yat-sen University Cancer Center 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3607312/ https://www.ncbi.nlm.nih.gov/pubmed/22257382 http://dx.doi.org/10.5732/cjc.011.10404

Ejemplares similares

Nanoparticle-Based Targeted Therapeutics in Head-And-Neck Cancer
por: Wu, Ting-Ting, et al.
Publicado: (2015)

Targeting Stress-Response Pathways and Therapeutic Resistance in Head and Neck Cancer
por: Bos, Tasia, et al.
Publicado: (2021)

Therapeutic Targeting of Cancer Stem Cells in Lung, Head and Neck, and Bladder Cancers
por: Mudra, Sarah E., et al.
Publicado: (2021)

Checkpoint Inhibitors in Cancer Therapy: Clinical Benefits for Head and Neck Cancers
por: Ettl, Tobias, et al.
Publicado: (2022)

Clinical and Therapeutic Considerations for Older Adults with Head and Neck Cancer
por: Dickstein, Daniel R, et al.
Publicado: (2023)

G-Protein-Coupled Receptors: Next Generation Therapeutic Targets in Head and Neck Cancer?
por: Kanazawa, Takeharu, et al.
Publicado: (2015)

Targeted therapy for head and neck cancer: signaling pathways and clinical studies
por: Li, Qingfang, et al.
Publicado: (2023)

Targeted Treatment of Head and Neck (Pre)Cancer: Preclinical Target Identification and Development of Novel Therapeutic Applications
por: van Harten, Anne M., et al.
Publicado: (2021)

MERTK as a novel therapeutic target in head and neck cancer
por: von Mässenhausen, Anne, et al.
Publicado: (2016)

Oral Mucositis Induced by Chemoradiotherapy in Head and Neck Cancer—A Short Review about the Therapeutic Management and the Benefits of Bee Honey
por: Jicman (Stan), Daniela, et al.
Publicado: (2022)

The Emerging Significance of Histone Lysine Demethylases as Prognostic Markers and Therapeutic Targets in Head and Neck Cancers
por: Dorna, Dawid, et al.
Publicado: (2022)

Role of DNA Methylation Profiles as Potential Biomarkers and Novel Therapeutic Targets in Head and Neck Cancer
por: Burkitt, Kyunghee
Publicado: (2023)

Genome Stability Pathways in Head and Neck Cancers
por: Jenkins, Glenn, et al.
Publicado: (2013)

Molecular Pathways and Druggable Targets in Head and Neck Squamous Cell Carcinoma
por: Kordbacheh, Farzaneh, et al.
Publicado: (2021)

Time to Surgery and Survival in Head and Neck Cancer
por: Heft Neal, Molly E., et al.
Publicado: (2020)

An update on angiogenesis targeting in head and neck squamous cell carcinoma
por: Micaily, Ida, et al.
Publicado: (2020)

Survival Benefit of Metformin as an Adjuvant Treatment for Head and Neck Cancer: A Systematic Review and Meta-Analysis
por: Jiao, Yu, et al.
Publicado: (2022)

The effect of radiotherapy on survival of dental implants in head and neck cancer patients
por: Shugaa-Addin, Bassam, et al.
Publicado: (2016)

Therapeutic implications of transcriptomics in head and neck cancer patient-derived xenografts
por: Lee, Rex H., et al.
Publicado: (2023)

Precision drugging of the MAPK pathway in head and neck cancer
por: Ngan, Hoi-Lam, et al.
Publicado: (2022)

IL-6 in the Ecosystem of Head and Neck Cancer: Possible Therapeutic Perspectives
por: Španko, Michal, et al.
Publicado: (2021)

Time to Surgery and Survival in Head and Neck Cancer
por: Rygalski, Chandler J., et al.
Publicado: (2020)

The role of EGFR-targeting strategies in the treatment of head and neck cancer
por: Dequanter, Didier, et al.
Publicado: (2012)

The Epithelial-Mesenchymal Transcription Factor Slug Predicts Survival Benefit of Up-Front Surgery in Head and Neck Cancer
por: Riechelmann, Herbert, et al.
Publicado: (2021)

Target Definition in MR-Guided Adaptive Radiotherapy for Head and Neck Cancer
por: de Ridder, Mischa, et al.
Publicado: (2022)

Wnt Signaling: A Potential Therapeutic Target in Head and Neck Squamous Cell Carcinoma
por: Javed, Zeeshan, et al.
Publicado: (2019)

Perioperative opioids and survival outcomes in resectable head and neck cancer: A systematic review
por: Mastrolonardo, Eric V., et al.
Publicado: (2023)

ROS-Mediated Therapeutic Strategy in Chemo-/Radiotherapy of Head and Neck Cancer
por: Huang, Gan, et al.
Publicado: (2020)

Therapeutic Targeting of MYC in Head and Neck Squamous Cell Carcinoma
por: Liu, Shuo, et al.
Publicado: (2022)

Preventive and Therapeutic Effect of Metformin in Head and Neck Cancer: A Concise Review
por: Bouland, Cyril, et al.
Publicado: (2023)

Hippo Pathway and YAP Signaling Alterations in Squamous Cancer of the Head and Neck
por: Santos-de-Frutos, Karla, et al.
Publicado: (2019)

Targeting Head and Neck Cancer by Vaccination
por: Wang, Chuan, et al.
Publicado: (2018)

Adaptive radiotherapy for head and neck cancer
por: Morgan, Howard E., et al.
Publicado: (2020)

Herpesviruses in Head and Neck Cancers
por: Wołącewicz, Mikołaj, et al.
Publicado: (2020)

Targeting NEDDylation as a Novel Approach to Improve the Treatment of Head and Neck Cancer
por: Jones, Trace M., et al.
Publicado: (2021)

Receptor-Tyrosine-Kinase-Targeted Therapies for Head and Neck Cancer
por: Elferink, Lisa A., et al.
Publicado: (2011)

Venous thromboembolism in head and neck cancer surgery
por: Ahmad, Faisal I., et al.
Publicado: (2016)

Therapeutic applications of botulinum neurotoxins in head and neck disorders
por: Alshadwi, Ahmad, et al.
Publicado: (2014)

Molecular targeted therapies in head and neck cancer - An update of recent developements -
por: Goerner, Martin, et al.
Publicado: (2010)

Progress of molecular targeted therapy for head and neck cancer in clinical aspects
por: Nakano, Kenji
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_chmsf6nrqemk2gbvi6938h6i0p